Reference:Reference-004571: Difference between revisions
From CSDMS
m Text replacement - "|MS_PublicationClusterID=2789925651" to "|MS_PublicationClusterID=2789925651 |Semantic_ID=da340a454b7abb42d0a6468908bd287a07703b18
" |
m Text replacement - " |Semantic_ID" to " |Semantic_ID" |
||
Line 15: | Line 15: | ||
|FeatureRef=No | |FeatureRef=No | ||
|PublicationClusterID=0 | |PublicationClusterID=0 | ||
|MS_PublicationClusterID=2789925651 |Semantic_ID=da340a454b7abb42d0a6468908bd287a07703b18 | |MS_PublicationClusterID=2789925651 | ||
|Semantic_ID=da340a454b7abb42d0a6468908bd287a07703b18 | |||
|PublicationWhatKindOf=a module application description | |PublicationWhatKindOf=a module application description | ||
|PublicationNrofModels=a single module | |PublicationNrofModels=a single module |
Revision as of 15:22, 9 January 2022
Author(s) | Li, Binghao; Zeng, Yang; Reeves, Patrick M.; Ran, Chongzhao; Liu, Qiuyan; Qu, Xiying; Liang, Yingying; Liu, Zhao; Yuan, Jianping; Leblanc, Pierre R.; Ye, Zhaoming; Sluder, Ann E.; Gelfand, Jeffrey A.; Brauns, Timothy A.; Chen, Huabiao; Poznansky, Mark C.; |
BibType | journalArticle |
Title | AMD3100 Augments the Efficacy of Mesothelin-Targeted, Immune-Activating VIC-008 in Mesothelioma by Modulating Intratumoral Immunosuppression |
Editors | |
Year | 2018-05-01 |
Journal | Cancer Immunology Research |
Booktitle | |
Volume | 6 |
Pages | 539–551 |
URL | http://cancerimmunolres.aacrjournals.org/lookup/doi/10.1158/2326-6066.CIR-17-0530 |
DOI | 10.1158/2326-6066.CIR-17-0530 |
ISBN | |
Note | Auto downloaded ref at: 2020-06-10
|
|
|
Feature reference | No |
PublicationClusterID | 0 |
MS_PublicationClusterID | 2789925651 |
Semantic_ID | da340a454b7abb42d0a6468908bd287a07703b18 |
Nr of citations | 31 |
Sort of publication | a module application description |
Sort of model publication | a single module |
Is the CSDMS HPC used | No |
If HPC is used, for what project was it?: | |
Associated simulation movie if any: |
|
Model(s) discussed: | VIC |